(Q42610828)
Statements
1 reference
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial (English)
1 reference
Josefina Alberú
1 reference
Michael D Pascoe
1 reference
Josep M Campistol
1 reference
Francesco P Schena
1 reference
Maria Del Carmen Rial
1 reference
Martin Polinsky
1 reference
John F Neylan
1 reference
Joan Korth-Bradley
1 reference
Robert Goldberg-Alberts
1 reference
Eric S Maller
1 reference
Sirolimus CONVERT Trial Study Group
1 reference
1 August 2011
1 reference
1 reference
92
1 reference
3
1 reference
303-310
1 reference
Identifiers
1 reference
1 reference